About Tal Zaks
Tal Zaks is an executive chairman of the board at Averna Therapeutics.
Form D filings also name Tal Zaks as a director at Curevo and Convergent Therapeutics.
Tal Zaks first appears on SEC filings in 2023.
Experience
This experience comes from Tal Zaks's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tal Zaks in the role, so the role may have started earlier or lasted longer.
Averna Therapeutics Inc. Current
Executive Chairman of the Board
2024 – Present · Watertown, MA
Develops gene insertion medicines for people with genetic diseases, cancer and autoimmune conditions.
Convergent Therapeutics, Inc. Current
Non Executive Director (2023 – Present)
Director
2023 – Present · Cambridge, MA
MA
Minervax ApS Current
Non Executive Director
2023 – Present
II
iECURE, inc. Current
Non Executive Director
2022 – Present
OR
OrbiMed Current
Partner, Private Equity
2021 – Present
TP
Teva Pharmaceuticals Current
Non Executive Director
2021 – Present
UP
University of Pennsylvania Current
Adjunct Associate Professor of Medicine, School of Medicine (2004 – Present)
Clinical Fellow (2002 – 2004)
2002 – Present
PT
PIC Therapeutics
Non Executive Director
2022 – 2025
AU
Adaptimmune US
Non Executive Director
2016 – 2023
MT
Moderna Therapeutics
Chief Medical Officer
2015 – 2021
SA
Sanofi
SVP, Head of Sanofi Oncology
2013 – 2015
SA
sanofi-aventis
VP, Head of Development, Oncology Division
2010 – 2014
VC
VA Medical Center
Attending, Medical Oncology
2008 – 2010
CE
Cephalon
VP, Clinical Research Oncology
2008 – 2010
GL
GlaxoSmithKline
Director, clinical development and translational medicine
2004 – 2008
TH
Temple University Hospital
Resident
1999 – 2002
NI
National Cancer Institute
Postdoctoral fellow
1996 – 1999
Key Colleagues at Startups
The people Tal Zaks works with at each company, as listed on that company's latest Form D.
Averna Therapeutics Inc. · Form D/A, Mar 20, 2026
Thomas Barnes
CEO & Board Member
Roy Amariglio
Board Member
Nick Olsen
Board Member
SS
Stephen Squinto
Director
MS
Michal Silverberg
Director
Raju Prasad
Board Member
Henry Chen
Board Member
DM
Dylan Morris
Board Member
Curevo, Inc. · Form D, Mar 18, 2025
MB
Mario Barro
Director
BB
Baeksik Bae
Director
CP
Charles Petty
Director
GM
Giovanni Mariggi
Director
MS
Moncef Slaoui
Director
GS
George Simeon
CEO and director
Convergent Therapeutics, Inc. · Form D, Aug 13, 2024
ES
Eric Sullivan
Executive officer
JS
Jake Simson
Director
JT
Jim Trenkle
Director
PK
Philip Kantoff
CEO and director
AB
Alexander Brown
Executive officer
NB
Neil Bander
Executive officer and director